Biochemistry and clinical significance of urokinase
Andrassy, K.; Ritz, E.
Deutsche Medizinische Wochenschrift 103(24) 1011: 1015-1020
1978
ISSN/ISBN: 0012-0472 PMID: 350536 Document Number: 129974
Document emailed within 1 workday
Related Documents
Duckert, F. 1971: Biochemistry of urokinase Folia Haematologica 95(2): 131-141Dayi, H.; Zhimin, X. 1997: Evaluation of the patency rate of infarct-related artery after intravenous urokinase in acute myocardial infarction by 90 minutes angiography. Collaborative Group of Clinical Trial for Urokinase Therapy Chinese Medical Journal 110(3): 184-186
Zhang, X.; Bu, X.; Zhen, H.; Fei, Z.; Wu, J.; Gu, J.; Yi, S.; Wang, Z. 2000: Expression and significance of urokinase-type plasminogen activator in human gliomas Chinese Medical Journal 113(9): 802-804
Taponeco, F.; Curcio, C.; Giuntini, A.; Nardini, V.; Fornaciari, G.; Artini, P.G.; D'Ambrogio, G.; Genazzani, A.R. 2001: Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer Journal of Experimental and Clinical Cancer Research: Cr 20(2): 239-246
Kirchheimer, J.C.; Nong, Y.H.; Remold, H.G. 1988: IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes Journal of Immunology 141(12): 4229-4234
Ueno, T.; Kobayashi, N.; Maekawa, T. 1979: Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase Thrombosis and Haemostasis 42(3): 885-894
Collen, D.; De Cock, F.; Lijnen, H.R. 1984: Biological and thrombolytic properties of proenzyme and active forms of human urokinase--II. Turnover of natural and recombinant urokinase in rabbits and squirrel monkeys Thrombosis and Haemostasis 52(1): 24-26
Geratz, J.D.; Shaver, S.R.; Tidwell, R.R. 1981: Inhibitory effect of amidino-substituted heterocyclic compounds on the amidase activity of plasmin and of high and low molecular weight urokinase and on urokinase-induced plasminogen activation Thrombosis Research 24(1-2): 73-83
Panteghini, M.; Clerico, A. 2004: Understanding the Clinical Biochemistry of N-Terminal Pro-B-Type Natriuretic Peptide: the Prerequisite for Its Optimal Clinical Use Clinical Laboratory 50(5-6): 325-331
Fischer, M. 1971: Clinical experiences with urokinase Folia Haematologica 95(2): 145-157
de Maat, M.P.; Dooijewaard, G.; Meijer, P.; Binder, B.R.; Keber, D.; Risberg, B.; Kluft, C.; Jespersen, J. 2001: Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase Enhancement Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 12(6): 453-458
Bizzi, B.; Leone, G.; Tutinelli, F.; Landolfi, R. 1978: Thrombolytic therapy with urokinase. Clinical trials La Clinica Terapeutica 86(5): 419-432
Masopust, J. 1976: Clinical biochemistry in pediatrics Ceskoslovenska Pediatrie 31(2): 89-92
Tan, I.K.; Jacob, E. 1989: Clinical biochemistry in Singapore Annals of the Academy of Medicine Singapore 18(4): 477-489
Homolka, J.; Masopust, J. 1973: Clinical biochemistry in Moscow Casopis Lekaru Ceskych 112(25): 789-790
Sunderman, F.W. 1990: The clinical biochemistry of 5'-nucleotidase Annals of Clinical and Laboratory Science 20(2): 123-139
Shiba, T.; Igarashi, M.; Takeuchi, S.; Awazu, S.; Asada, T. 1978: Experimental and clinical studies on thrombolytic therapy with urokinase Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(4): 771-781
Fruton, J.S. 1982: Biochemistry and clinical chemistry--a retrospect Journal of Clinical Chemistry and Clinical Biochemistry 20(4): 243-252
Doss, M. 1977: Clinical biochemistry: emphasis on porphyria Fortschritte der Medizin 95(42): 2517-2518; 2537
Niederland, T.R. 1977: Perspectives of clinical biochemistry in hepatology Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 32(2): 26-29